The current treatment of obliterative bronchiolitis in lung transplant recipients is sub-optimal. Triptolide is a novel immunosuppressant that has a mechanism of action distinct from currently available immunosuppressants, including induction of T-cell apoptosis, blockade of fibroblast proliferation/maturation and inhibition of transforming growth factor-beta (TGF-beta) mRNA production. We hypothesized that triptolide may be helpful in blocking obliterative airway disease in lung transplant recipients. We investigated the effect of PG490-88, a water-soluble derivative of triptolide, in a mouse heterotopic tracheal allograft model of obliterative airway disease. We show that PG490-88 attenuates airway obliteration in this model and inhibits accumulation of inflammatory cells, and therefore may have preventive or therapeutic benefits for patients with obliterative airway disease (OAD) following lung transplantation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s1053-2498(02)00449-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib.
Eur Thyroid J
October 2024
Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Pisa, Italy.
Article Synopsis
- A highly selective RET inhibitor called selpercatinib has shown significant effectiveness in treating advanced RET-mutant medullary thyroid cancer, despite having some side effects.
- A 70-year-old patient experienced a rare side effect known as obliterative bronchiolitis (OB) while receiving the treatment, which led to inflammation and fibrosis in his lungs.
- Although the patient developed OB, he still showed a partial response to the cancer treatment, indicating the need for careful consideration of the balance between managing side effects and the efficacy of ongoing cancer therapy.
Iron Overload-induced Ferroptosis as a Target for Protection against Obliterative Bronchiolitis after Orthotopic Tracheal Transplantation in Mice.
Curr Mol Med
June 2024
Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Introduction: The major complication of Obliterative Bronchiolitis (OB) is characterized by epithelial cell loss, fibrosis, and luminal occlusion of the terminal small airways, which limits the long-term survival of the recipient after lung transplantation. However, the underlying mechanisms are still not fully clarified. This research aims to investigate whether iron overload-induced ferroptosis is involved in OB development and provide a new target for OB prevention.
View Article and Find Full Text PDFMurine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation.
J Vis Exp
November 2023
Latner Thoracic Research Laboratories, Toronto General Hospital Research Institute, University Health Network; Temerty Faculty of Medicine, University of Toronto;
Murine intrapulmonary tracheal transplantation (IPTT) is used as a model of obliterative airway disease (OAD) following lung transplantation. Initially reported by our team, this model has gained use in the study of OAD due to its high technical reproducibility and suitability for investigating immunological behaviors and therapeutic interventions. In the IPTT model, a rodent tracheal graft is directly inserted into the recipient's lung through the pleura.
View Article and Find Full Text PDFDonor IL-17 receptor A regulates LPS-potentiated acute and chronic murine lung allograft rejection.
JCI Insight
November 2023
Latner Thoracic Research Laboratories, University Health Network, Toronto, Ontario, Canada.
Chronic lung allograft dysfunction (CLAD) is a major complication after lung transplantation that results from a complex interplay of innate inflammatory and alloimmune factors, culminating in parenchymal and/or obliterative airway fibrosis. Excessive IL-17A signaling and chronic inflammation have been recognized as key factors in these pathological processes. Herein, we developed a model of repeated airway inflammation in mouse minor alloantigen-mismatched single-lung transplantation.
View Article and Find Full Text PDFPrimary immunodeficiency diseases of adults: a review of pulmonary complication imaging findings.
Eur Radiol
June 2024
Department of Pneumology, Hôpital Foch, Suresnes, France.
Our objective in this review is to familiarize radiologists with the spectrum of initial and progressive CT manifestations of pulmonary complications observed in adult patients with primary immunodeficiency diseases, including primary antibody deficiency (PAD), hyper-IgE syndrome (HIES), and chronic granulomatous disease (CGD). In patients with PAD, recurrent pulmonary infections may lead to airway remodeling with bronchial wall-thickening, bronchiectasis, mucus-plugging, mosaic perfusion, and expiratory air-trapping. Interstitial lung disease associates pulmonary lymphoid hyperplasia, granulomatous inflammation, and organizing pneumonia and is called granulomatous-lymphocytic interstitial lung disease (GLILD).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!